0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe
- RxCUI
- 798429
- RxNorm name
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe
- Display name
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe
- Full name
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103239 | Engerix-B | Hepatitis B Vaccine (Recombinant) | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2ec65f7e-4aa2-4b41-b578-885ea59d6e9d | hepatitis B vaccine (recombinant) pediatric/adolescent 10 MCG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [SCD] · hepatitis B surface antigen vaccine 0.01 MG per 0.5 ML Prefilled Syringe [SY] · hepatitis B surface antigen vaccine 10 MCG per 0.5 ML Prefilled Syringe [SY] | 4 | 34 | These highlights do not include all the information needed to use ENGERIX-B safely and effectively. See full prescribing information for ENGERIX-B. ENGERIX-B [Hepatitis B Vaccine (Recombinant)] injectable suspension, for intramuscular use Initial U.S. Approval: 1989 | 20260514 |
| 9a4037a2-6c63-457a-8d6f-2fd05d926ea2 | hepatitis B vaccine (recombinant) pediatric/adolescent 10 MCG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [SCD] · hepatitis B surface antigen vaccine 0.01 MG per 0.5 ML Prefilled Syringe [SY] · hepatitis B surface antigen vaccine 10 MCG per 0.5 ML Prefilled Syringe [SY] | 4 | 13 | These highlights do not include all the information needed to use ENGERIX-B safely and effectively. See full prescribing information for ENGERIX-B. ENGERIX-B [Hepatitis B Vaccine (Recombinant)] Suspension for Intramuscular Injection Initial U.S. Approval: 1989 | 20200118 |